Mthera Pharma specializes in biopharmaceutical research and development using a Multi-Target (MCMT) approach, which enables the identification and targeting of multiple disease pathways simultaneously. The company focuses on leveraging big data and advanced technologies to enhance drug discovery and development, addressing the inefficiencies in traditional pharmaceutical R&D processes.
Funding
$10K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional pharmaceutical research and development processes are often inefficient due to the complexity of biological systems and the challenges in identifying effective drug targets. Developing new drugs is time-consuming and costly, with a high failure rate due to the inability to address multiple disease pathways simultaneously.
Solution
Mthera Pharma utilizes a Multi-Target (MCMT) approach to biopharmaceutical research and development, enabling the simultaneous targeting of multiple disease pathways. The company leverages big data analysis, AI-based bio-fingerprinting, and cutting-edge CMC (Chemistry, Manufacturing, and Controls) technology to enhance drug discovery and development. By integrating traditional knowledge, biomass resources, and advanced omics technologies like microbiome and metabolomics, Mthera Pharma aims to identify and develop more effective therapeutic interventions. Their approach seeks to improve the efficiency and success rate of pharmaceutical R&D by addressing the limitations of single-target drug development.
Target Audience
Mthera Pharma's primary customers are pharmaceutical companies and research institutions seeking innovative drug development strategies and more effective therapeutic interventions.
Features
- Multi-Target (MCMT) approach for simultaneous targeting of multiple disease pathways
- AI-based bio-fingerprinting for enhanced drug target identification
- Cutting-edge CMC (Chemistry, Manufacturing, and Controls) technology for drug development
- Integration of big data analysis for identifying potential drug candidates
- Utilization of microbiome and metabolomics data for comprehensive biological understanding
- Expertise in traditional knowledge and biomass resources for novel drug discovery